Post-ptca restenosis inhibitor

Details Post-ptca restenosis inhibitor Post-ptca restenosis inhibitor

A - Human Necessities

61

K

167/228, 167/234

A61K 31/44 (2006.01) A61K 31/415 (2006.01) A61K 31/425 (2006.01)

Patent

CA 2010964

ABSTRACT OF THE DISCLOSURE A restenosis inhibiting agent for the treatment or prevention of restenosis after percutaneous trans- luminal coronary angioplasty which comprises a pharmaceutically effective amount of a compound of the following general formula or a pharmaceutically accept- able salt thereof as an active ingredient: Image (I) wherein R is an imidazolyl group, a thiazolyl group or a pyridyl group, n is an integer of 1 or 2, and m is an integer of 1 to 4.

Affiliated with

Also associated with

Rating

Post-ptca restenosis inhibitor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Post-ptca restenosis inhibitor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Post-ptca restenosis inhibitor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1947216